A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart

Cardiovascular Pathology

Volumn 16, Issue 3, 2007, Pages 127-135

  Qian, Cheng ^a   Tio, René A ^a   Roks, Anton J M ^a   Boddeus, Kristien M ^a   Harmsen, Martin C ^a   van Gilst, Wiek H ^a   Schoemaker, Regien G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Distribution; Endothelial progenitor cell; Intracoronary administration; Rat heart; Transplantation

Indexed keywords

BROXURIDINE; LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; RAT; STAINING; STEM CELL;

ANIMALS; BONE MARROW CELLS; BROMODEOXYURIDINE; CARDIAC SURGICAL PROCEDURES; CELL COUNT; ENDOTHELIUM, VASCULAR; HEART VENTRICLES; INJECTIONS, INTRAMUSCULAR; KIDNEY; LIVER; LUNG; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; SPLEEN; STEM CELL TRANSPLANTATION; TISSUE DISTRIBUTION;

EID: 34248210174     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2006.11.008     Document Type: Article

References (32)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182-1186
2. Risau W., and Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 11 (1995) 73-91
3. Poole T., and Coffin J. Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. J Exp Zool 251 (1989) 224-231
4. Coffin J., Harrison J., Schwartz S., and Heimark R. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev Biol 148 (1991) 51-62
5. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
6. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
7. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
8. Griese D., Ehsan A., Melo L., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108 (2003) 2710-2715
9. Eggermann J., Kliche S., Jarmy G., et al. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58 (2003) 478-486
10. Boyer M., Townsend L., Vogel L., et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 31 (2000) 181-189
11. Isner J., and Takayuki A. Therapeutic angiogenesis. Front Biosci 3 (1998) e49-e69
12. Perin E., Dohmann H., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
13. Fuchs S., Baffour R., Zhou Y., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37 (2001) 1726-1732
14. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93 (2003) e17-e24
15. Herreros J., Prosper F., Perez A., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur J Heart 24 (2003) 2012-2020
16. Hajjar R., Schmidt U., Matsui T., et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A 95 (1998) 5251-5256
17. Kawamoto A., Gwon H., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
18. Buikema H., Monnink S., Tio R., Crijns H., de Zeeuw D., and van Gilst W. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol 130 (2000) 1999-2007
19. Loot A., Henning R., Deelman L., et al. Semliki Forest virus is an efficient and selective vector for gene delivery in infarcted rat heart. J Mol Cell Cardiol 37 (2004) 137-142
20. Roth D., Lai N., Gao M., et al. Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice. Am J Physiol Heart Circ Physiol 287 (2004) H172-H177
21. Min J., Huang X., Xiang M., et al. Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiovasc Surg 131 (2006) 889-897
22. Hristov M., Erl W., and Weber P. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23 (2003) 1185-1189
23. Annabi B., Lee Y., Turcotte S., et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 21 (2003) 337-347
24. Akita T., Murohara T., Ikeda H., et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 83 (2003) 65-73
25. Ii M., Nishimura H., Iwakura A., et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 111 (2005) 1114-1120
26. Ghosh S., Standen N., and Galinianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 37 (2001) 711-718
27. Ma J., Ge J., Zhang S., et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 100 (2005) 217-223
28. Harmsen E., Schoemaker R., Yu J., Ruzicka M., and Leenen F. Sensitivity to ischaemic ATP breakdown in different models of cardiac hypertrophy in rats. J Hypertens 12 (1994) 49-57
29. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
30. Tepper O., Galiano R., Capla J., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
31. Bahlmann F., DeGroot K., Duckert T., et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 64 (2003) 1648-1652
32. Walter D., Rittig K., Bahlmann F., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024